Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)
ClinicalTrials.gov study NCT04706793. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT04173273. IPD Sharing: YES. Countries: 41. Publications: 1.
Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)
ClinicalTrials.gov study NCT01261793. IPD Sharing: Not stated. Countries: 16. Publications: 2.
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
ClinicalTrials.gov study NCT01930214. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab
ClinicalTrials.gov study NCT01543204. IPD Sharing: Not stated. Countries: 2. Publications: 1.
To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitis
ClinicalTrials.gov study NCT02683928. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia
ClinicalTrials.gov study NCT01493024. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment
ClinicalTrials.gov study NCT01818596. IPD Sharing: YES. Countries: 9. Publications: 2.
A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)
ClinicalTrials.gov study NCT01597245. IPD Sharing: YES. Countries: 12. Publications: 11.
Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy
ClinicalTrials.gov study NCT02886728. IPD Sharing: NO. Countries: 31. Publications: 8.
A Study of Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies
ClinicalTrials.gov study NCT00249808. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne
ClinicalTrials.gov study NCT03709654. IPD Sharing: NO. Countries: 1. Publications: 4.
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT00487539. IPD Sharing: Not stated. Countries: 25. Publications: 3.
A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.
ClinicalTrials.gov study NCT03675477. IPD Sharing: NO. Countries: 5. Publications: 1.
Apremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS)
ClinicalTrials.gov study NCT04572997. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis
ClinicalTrials.gov study NCT01815424. IPD Sharing: YES. Countries: 3. Publications: 1.
A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03364309. IPD Sharing: YES. Countries: 1. Publications: 2.
Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women
ClinicalTrials.gov study NCT00611533. IPD Sharing: Not stated. Countries: 1. Publications: 5.
An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT01951170. IPD Sharing: Not stated. Countries: 1. Publications: 3.
AD109 Dose Finding in Mild to Moderate OSA
ClinicalTrials.gov study NCT04631107. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.